Gene Variant Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene JAK3
Variant H583Y
Impact List missense
Protein Effect gain of function - predicted
Gene Variant Descriptions JAK3 H583Y lies within protein kinase domain 1 of the Jak3 protein (UniProt.org). H583Y has not been biochemically characterized, but results in transformation of cells in culture (PMID: 28284718), and therefore, is predicted to lead to a gain of Jak3 protein function.
Associated Drug Resistance
Category Variants Paths

JAK3 mutant JAK3 act mut JAK3 H583Y

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000215.4
gDNA chr19:g.17837168G>A
cDNA c.1747C>T
Protein p.H583Y
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
NM_000215.3 chr19:g.17837168G>A c.1747C>T p.H583Y RefSeq GRCh38/hg38
XM_011527991.3 chr19:g.17837168G>A c.1747C>T p.H583Y RefSeq GRCh38/hg38
XM_047438786.1 chr19:g.17837168G>A c.1747C>T p.H583Y RefSeq GRCh38/hg38
NM_000215 chr19:g.17837168G>A c.1747C>T p.H583Y RefSeq GRCh38/hg38
NM_000215.4 chr19:g.17837168G>A c.1747C>T p.H583Y RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
JAK3 H583Y hematologic cancer sensitive Tofacitinib Preclinical - Cell culture Actionable In a preclinical study, Xeljanz (tofacitinib) decreased viability of transformed mouse Ba/F3 cells expressing JAK3 H583Y (PMID: 28284718). 28284718